Multigene Testing of Everyone Dx W/ BC Deemed Cost-Effective

Options
Moderators
Moderators Member Posts: 25,912
edited October 2019 in Genetic Testing

Multigene Testing of Everyone Diagnosed With Breast Cancer Deemed Cost-Effective, and Researchers Say Policies Should Change
October 8, 2019
A study found testing all people diagnosed with breast cancer for mutations in three genes linked to a high risk of the disease — BRCA1, BRCA2, and PALB2 — would be "extremely cost-effective" compared to testing based on family history or clinical guidelines in the United States and the United Kingdom. Read more...

· Share on FacebookShare on Twitter

Categories